Cart
sales@molnova.com
Home - Products - Angiogenesis - VEGFR - BIBF 1202

BIBF 1202

CAS No. 894783-71-2

BIBF 1202( —— )

Catalog No. M29632 CAS No. 894783-71-2

BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 In Stock
25MG 179 In Stock
50MG 259 In Stock
100MG 379 In Stock
200MG 537 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    BIBF 1202
  • Note
    Research use only, not for human use.
  • Brief Description
    BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).
  • Description
    BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).(In Vitro):BIBF 1202 is produced in the main metabolic pathway of BIBF 1120 by the cleavage of methyl esters. Then, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acyl glucuronide .
  • In Vitro
    The major metabolic pathway for BIBF 1120 is methyl ester cleavage to BIBF 1202. Subsequently, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acylglucuronide.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    894783-71-2
  • Formula Weight
    525.609
  • Molecular Formula
    C30H31N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 45 mg/mL (85.62 mM)
  • SMILES
    CN(C(=O)CN1CCN(C)CC1)c1ccc(N\C(=C2/C(=O)Nc3cc(ccc23)C(O)=O)c2ccccc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Bevacizumab

    Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.

  • CL-387785

    CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR(IC50： 370+/-120 pM);is able to overcome resistance caused by the T790M mutation on a functional level.

  • TG 100572 Hydrochlor...

    TG 100572 Hydrochloride is a inhibitor of multi-targeted kinase which inhibits receptor tyrosine kinases and Src kinases.

Sign In Join Free